MicroPort® CRM

MicroPort® completes the acquisition of the Cardiac Rhythm Management business from LivaNova.

London and Shanghai – On April 30, 2018, MicroPort Scientific Corporation (HK: 00853) (“MicroPort®“) announced the closing of the transaction to acquire the Cardiac Rhythm Management (“CRM”) Business from LivaNova PLC (NASDAQ:LIVN) (“LivaNova”).

Upon completion of the acquisition, the acquired CRM Business is now officially rebranded as MicroPort® CRM. This acquisition is expected to establish MicroPort® CRM as the fifth largest CRM business in the world and make MicroPort® the most advanced domestic company in China with CRM know-how in the global CRM market.

Disclaimer
Privacyverklaring
Cookieverklaring
Statuten
Reglement

Patiënteninformatie
Deze website is bedoeld voor de beroepsgroep Technische Hartstimulatie Specialisten.
ICD patiënten verwijzen wij naar de Stichting ICD dragers Nederland (STIN). 
Pacemakerpatiënten verwijzen we naar de Nederlandse Hartstichting.